Kevin Tang of Fulcrum Therapeutics purchased 249,946 shares of FULC for $3.56 each on Wednesday, totaling $891,067. As of Thursday, the stock peaked at $3.78, marking a 5.9% gain at its highest point. This is Tang’s first insider buy in the past year.
Similarly, Richard M. Rieder acquired 35,734 shares of Blackrock Esg Capital Allocation Term Trust (ECAT) at $15.86 each on Monday for a total of $566,648, also his first purchase in a year. On Thursday, ECAT shares traded as low as $15.61, representing a 1.6% drop below Rieder’s purchase price.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
